Follow us on social media
1-801-359-7400 | [email protected]

Research News

A Report of Research Progress in 2016

Research Progress

Because of the investment of many supporters – donors large and small – the Bateman Horne Center (BHC) has been able to partner with cutting-edge researchers across the globe. BHC works directly with researchers to enroll well-categorized patients into their research, providing samples with material transfer agreements in place so that we continue to learn from…

Read More

Global Report of Progress with Lucinda Bateman, M.D.

progress report

An ME/CS Progress Report Lucinda Bateman, MD, BHC Founder and Medical Director, is actively engaged in ME/CFS and FM thought leadership across the globe. In October she was on the road to take part in and advance the discussions that lead to progress. In a few short weeks she participated in: October 8th – SMCI Scientific…

Read More

What’s the Buzz – October

Whats the Buzz

Buzz – October: Each month we scour the Internet to bring you a summary of news articles, blogs and research publications we think you’ll find interesting for our What’s the Buzz post. This month, Suzanne D. Vernon, PhD, BHC Research Liaison, highlights and summarize two recent research publications for you:   The Importance of Measuring Symptoms ME/CFS is…

Read More

What’s the Buzz – September

Buzz - January 2017

Buzz – September: Each month we scour the Internet and bring you a list of news articles, blogs and research publications we think you’ll find interesting for our What’s the Buzz post.   Occasionally, we’ll highlight and summarize a few of them for you, like this one:   Confirming a Potential ME/CFS Biomarker by Suzanne D. Vernon, PhD  |…

Read More

What’s the Buzz – July

Whats the Buzz

  Buzz – July: Each month we scour the Internet and bring you a list of news articles, blogs and research publications we think you’ll find interesting for our What’s the Buzz post. Occasionally, we’ll highlight and summarize a few of them for you, like this one:   Could Difference in Gut Bacteria Help Explain ME/CFS Symptoms? Suzanne D.…

Read More

Bateman Horne Center Response to NIH RFI

NIH RFI

BHC prepared the following response the NIH Request For Information (RFI) regarding the future of ME/CFS research Sixteen different centers within the NIH sought input concerning new research strategies for ME/CFS. They asked patients and advocates to tell the Trans-NIH Working Group on ME/CFS what kind of opportunities they see for studying the illness, what technologies and…

Read More

CDC CFS Patient-Centered Outreach Call

CDC Conf Call

CFS Patient-centered outreach and communication activity (PCOCA) Conference Call Thursday, June 23, 2016 3:00 pm – 4:00 pm EDT   Call number: 1-800-369-2100 Participant Code: 7673924     The latest of the US Centers for Disease Control’s (CDC’s) Patient-Centered Outreach and Communication Activity (PCOCA) telephone conference calls for ME/CFS will take place on Thursday, June…

Read More

NIH Charting It’s Course for ME/CFS

NIH

Sixteen different centers within the NIH have come together to seek input concerning new research strategies for ME/CFS. They are asking patients and patient advocates to tell the Trans-NIH Working Group on ME/CFS what kind of opportunities there are for studying the illness, what technologies and tests might be utilized in studying it, and what challenges ME/CFS…

Read More

Biomarkers or Bust

Biomarkers or bust

Dr. Vernon explains why for the Bateman Horne Center, the identification of biomarkers is mission-critical… It’s Biomarkers or Bust! __________ Back in 2008 when I was advocating on the Hill and at NIH for greater research dollars for ME/CFS research I was told, “Identify biomarkers and increased research dollars will follow.”  A Catch 22 if…

Read More

$3.28 Million Awarded for ME/CFS Biomarker Study

Biomarker Study

Bateman Horne Center Leadership are Co-Investigators on this Cutting-Edge Immunogenomic Study to Quantify ME/CFS Moving Toward a Genomic CBC for ME/CFS By Suzanne D Vernon, PhD There are two major barriers to identifying ME/CFS biomarkers: 1) variation in how patients are effected, in terms of symptoms and disease progression and 2) the lack of quantitative tools…

Read More